Effect of Pamidronate on treatment of bone pains

Phase 2

• Conditions: Condition 1: Bone pains in Cancer patients with bone metastases. Condition 2: Hypercalcemia in Cancer patients with bone metastases. Condition 3: Quality of life in Cancer patients with bone metastases.; Secondary malignant neoplasm of bone and bone marrow; Disorders of calcium metabolism; Lifestyle-related condition

• Registration Number: IRCT2013032212197N5
• Lead Sponsor: Vice chancellor for research of Tonekabon Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

Malignancy with bone metastasis
Exclusion criteria:
Renal dysfunction history,
Creatinine more than 2mg/dl,
Treatment of Hypocalcemia with other Bisphosphonates

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bone pains. Timepoint: Before intervention - 3 months after intervention. Method of measurement: Visual Analoge Scale.

Secondary Outcome Measures

Name	Time	Method
Taking Sedatives. Timepoint: Before intervention - 3 months after intervention. Method of measurement: Questionnaire including Clinical data.;Taking Opiums. Timepoint: Before intervention - 3 months after intervention. Method of measurement: Questionnaire including Clinical data.